Cargando…
IL-6 and ovarian cancer: inflammatory cytokines in promotion of metastasis
Ovarian cancer is the most fatal gynecological cancer in the USA and the fifth most common cancer-related cause of death in women. Inflammation has been shown to play many roles in ovarian cancer tumor growth, with the proinflammatory cytokine interleukin-6 (IL-6) having been established as a key im...
Autores principales: | Browning, Landon, Patel, Megha R, Horvath, Eli Bring, Tawara, Ken, Jorcyk, Cheryl L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287645/ https://www.ncbi.nlm.nih.gov/pubmed/30584363 http://dx.doi.org/10.2147/CMAR.S179189 |
Ejemplares similares
-
Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies
por: Tawara, Ken, et al.
Publicado: (2011) -
Co-Expression of VEGF and IL-6 Family Cytokines is Associated with Decreased Survival in HER2 Negative Breast Cancer Patients: Subtype-Specific IL-6 Family Cytokine-Mediated VEGF Secretion()()
por: Tawara, Ken, et al.
Publicado: (2018) -
Stüve-Wiedemann syndrome: LIFR and associated cytokines in clinical course and etiology
por: Mikelonis, Dawn, et al.
Publicado: (2014) -
HIGH expression of OSM and IL-6 are associated with decreased breast cancer survival: synergistic induction of IL-6 secretion by OSM and IL-1β
por: Tawara, Ken, et al.
Publicado: (2019) -
Novel mouse mammary cell lines for in vivo bioluminescence imaging (BLI) of bone metastasis
por: Bolin, Celeste, et al.
Publicado: (2012)